Raffles Medical Group Ltd
BSL.SI
Stock Exchange of Singapore0.92
SGD
-0.01
- -
Raffles Medical Group Ltd
BSL.SI
(Stock Exchange of Singapore)
Recent
price
0.92
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Raffles Medical Group Ltd (SGX: BSL) operates as one of Asia's leading integrated private healthcare providers, delivering a comprehensive continuum of primary, secondary, tertiary, and wellness care services through its network of facilities across Singapore, China, Japan, Vietnam, and Cambodia. The company owns and manages Raffles Hospital, a tertiary care facility in Singapore featuring over 25 specialist centres covering cardiology, oncology, orthopaedics, obstetrics and gynaecology, neurology, and other disciplines including 24-hour acute and critical care, inpatient wards, intensive care units, and advanced diagnostic services such as radiology, nuclear medicine, and angiography suites; a network exceeding 100 multi-disciplinary clinics under Raffles Medical offering family medicine, emergency services, health screenings, vaccinations, travel health, minor surgery, X-ray, corporate programmes, and government healthcare schemes; Raffles Dental providing general and specialist dentistry; Raffles Chinese Medicine delivering acupuncture, herbal treatments, and co-management with Western specialists for fertility, pain, and women's health; Raffles Health Insurance issuing individual and corporate health policies including integrated shield plans like Raffles Shield and critical illness coverage; and Raffles Health, its consumer healthcare division, developing and distributing nutraceuticals, vitamins, supplements, and diagnostic equipment. Raffles Healthcare Institute supports training for medical professionals in family medicine, dentistry, nursing, and allied health. Headquartered in Singapore and founded in 1976, the group serves over 2.8 million patients and 7,000 corporate clients annually through operations in 14 cities including Singapore; Chongqing, Shanghai, Beijing, Tianjin, Dalian, and Nanjing in China; Hanoi, Ho Chi Minh City, and Vung Tau in Vietnam; Phnom Penh in Cambodia; Fukuoka and Osaka in Japan; and representative offices in Indonesia, Bangladesh, and Brunei, with airport clinics at Singapore's Changi and Hong Kong's Chek Lap Kok International Airports. In recent developments, Raffles Medical Group has expanded strategic partnerships in China, including alliances signed in March 2025 with Shanghai's Renji Hospital and in June 2025 with Chongqing's First Affiliated Hospital to establish cross-border medical cooperation models integrating international standards with local expertise, enhancing patient access to specialists and supporting China's Healthy China 2030 initiative; a memorandum of understanding with AIA Singapore to integrate over 90 Raffles specialists into its Quality Healthcare Partners panel, streamlining claims and promoting value-based care; and an October 2025 MOU with Gene Solutions to accelerate oncology clinical trials and precision medicine in Southeast Asia. The group also reported 1H 2025 revenue growth of 3.5% to S$378.4 million and profit after tax up 5.0% to S$32.5 million, bolstered by Hospital Services and reduced losses in Raffles Health Insurance through enhanced claims management, while revising its dividend policy to at least 50% of sustainable earnings and authorizing up to 100 million share buybacks over two years.